Journal of Viral Hepatitis

Papers
(The H4-Index of Journal of Viral Hepatitis is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
International disease burden of acute viral hepatitis among adolescents and young adults: An observational study36
Issue Information30
Issue Information28
28
Baseline Alpha‐Fetoprotein Elevation and the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B: A Multicentre Cohort Study25
Issue Information24
Hepatitis E Infection in Immunocompromised Patients Previously Treated With Rituximab23
Clinical Observational Study on HBV Reactivation After Direct‐Acting Antiviral Therapy in HCV / 22
240‐week entecavir maleate treatment in Chinese chronic hepatitis B predominantly genotype B or C22
Early virologic relapse predicts alanine aminotransferase flares after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B20
The role of serum sphingolipids as potential biomarkers of non‐response to direct acting antiviral therapy in chronic hepatitis C virus infection20
A cross‐sectional study of hepatitis C prevalence and correlates among persons who inject drugs in rural and non‐rural communities19
Hepatitis A occurrence and outbreaks in Europe over the past two decades: A systematic review19
Serum HBV RNA predicts HBeAg clearance and seroconversion in patients with chronic hepatitis B treated with nucleos(t)ide analogues19
Falling treatment uptake in the hepatitis C care cascade is a growing threat to achieving elimination17
Investigating rates and risk factors for hepatitis C virus reinfection in people receiving antiviral treatment in England17
Persistence of immunity against hepatitis A in Brazilian children vaccinated with a single dose of inactivated virus vaccine17
Cost‐effectiveness analysis of an active search to retrieve HCV patients lost to follow‐up (RELINK‐C strategy) and the impact of COVID‐1917
0.15547299385071